Fresh analysis indicates that patients who stop using new slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle plans.
Published data in a prominent health publication demonstrates that while obese individuals often shed a large proportion of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing these medications must be cognizant of the danger of fast weight regain when the therapy is stopped," warns researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to starting mass within about 18 months.
Analyzing Approaches
The analysis, which examined dozens of studies involving over 9,000 of patients, compared the results of the injectable medications with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise generally see a slower weight regain—around 100 grams monthly—post-intervention.
Explaining the Fast Regain
Experts propose the way of the drugs explains the amplified regain.
These medications mimic a natural hormone called GLP-1, which controls appetite.
"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this GLP-1 'fix' means hunger is unsuppressed, making binge eating a significant risk."
An Ongoing Condition?
Health authorities suggest the jabs for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the treatment might need to be ongoing.
This opinion is reinforced by drug manufacturers, who note that the results "highlight the persistent nature of obesity," akin to managing conditions like hypertension.
Patient Testimonies
Individuals who have stopped the medication explain a powerful return of cravings.
"It felt as if a switch activating and you become ravenous," said an individual.
The struggle is worsened if users have not established lasting dietary or behavioural changes during treatment.
Growing Use
Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is higher among females than men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
In conclusion, researchers caution that while GLP-1 drugs are potent tools for weight loss, they are not a permanent solution and maintained weight loss likely depends on ongoing behavioural changes.
